Literature DB >> 34448085

Undetectable NK Cells due to the FCGR3A Variant, L66H, Which May Not Be Directly Disease-Causing.

Maurice R G O'Gorman1, Joseph A Church2, Neema Izadi3, Miao Sun4, Emily M Mace5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34448085      PMCID： PMC9095344          DOI： 10.1007/s10875-021-01122-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  6 in total

1.  Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: A working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology.

Authors:  Ivan K Chinn; Alice Y Chan; Karin Chen; Janet Chou; Morna J Dorsey; Joud Hajjar; Artemio M Jongco; Michael D Keller; Lisa J Kobrynski; Attila Kumanovics; Monica G Lawrence; Jennifer W Leiding; Patricia L Lugar; Jordan S Orange; Kiran Patel; Craig D Platt; Jennifer M Puck; Nikita Raje; Neil Romberg; Maria A Slack; Kathleen E Sullivan; Teresa K Tarrant; Troy R Torgerson; Jolan E Walter
Journal:  J Allergy Clin Immunol       Date:  2019-09-27       Impact factor: 10.793

2.  Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections.

Authors:  E de Vries; H R Koene; J M Vossen; J W Gratama; A E von dem Borne; J L Waaijer; A Haraldsson; M de Haas; M J van Tol
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

3.  The loss of the CD16 B73.1/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L/R/H polymorphism.

Authors:  Marzena Lenart; Elzbieta Trzyna; Magdalena Rutkowska; Karolina Bukowska-Strakova; Anna Szaflarska; Anna Pituch-Noworolska; Antoni Szczepanik; Marek Zembala; Maciej Siedlar
Journal:  Int J Mol Med       Date:  2010-09       Impact factor: 4.101

4.  Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity.

Authors:  Jennifer T Grier; Lisa R Forbes; Linda Monaco-Shawver; Jennifer Oshinsky; T Prescott Atkinson; Curtis Moody; Rahul Pandey; Kerry S Campbell; Jordan S Orange
Journal:  J Clin Invest       Date:  2012-09-24       Impact factor: 14.808

5.  Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II).

Authors:  S Jawahar; C Moody; M Chan; R Finberg; R Geha; T Chatila
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

6.  The mutational constraint spectrum quantified from variation in 141,456 humans.

Authors:  Konrad J Karczewski; Laurent C Francioli; Grace Tiao; Beryl B Cummings; Jessica Alföldi; Qingbo Wang; Ryan L Collins; Kristen M Laricchia; Andrea Ganna; Daniel P Birnbaum; Laura D Gauthier; Harrison Brand; Matthew Solomonson; Nicholas A Watts; Daniel Rhodes; Moriel Singer-Berk; Eleina M England; Eleanor G Seaby; Jack A Kosmicki; Raymond K Walters; Katherine Tashman; Yossi Farjoun; Eric Banks; Timothy Poterba; Arcturus Wang; Cotton Seed; Nicola Whiffin; Jessica X Chong; Kaitlin E Samocha; Emma Pierce-Hoffman; Zachary Zappala; Anne H O'Donnell-Luria; Eric Vallabh Minikel; Ben Weisburd; Monkol Lek; James S Ware; Christopher Vittal; Irina M Armean; Louis Bergelson; Kristian Cibulskis; Kristen M Connolly; Miguel Covarrubias; Stacey Donnelly; Steven Ferriera; Stacey Gabriel; Jeff Gentry; Namrata Gupta; Thibault Jeandet; Diane Kaplan; Christopher Llanwarne; Ruchi Munshi; Sam Novod; Nikelle Petrillo; David Roazen; Valentin Ruano-Rubio; Andrea Saltzman; Molly Schleicher; Jose Soto; Kathleen Tibbetts; Charlotte Tolonen; Gordon Wade; Michael E Talkowski; Benjamin M Neale; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2020-05-27       Impact factor: 69.504
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.